{"result_id": "086032", "URL": "https://www.cureus.com/articles/114605-administration-of-the-second-dose-of-mrna-covid-19-vaccine-to-a-woman-with-immediate-reaction-to-the-first-dose", "timestamp": "2023-04-25 14:53:26 CEST+0200", "meta": {"description": "Vaccines constitute the most effective\u00a0public health intervention as they\u00a0prevent the spread of infectious diseases and reduce disease severity and mortality. Allergic reactions can occur during vaccination. Systemic anaphylaxis is a severe, life-threatening allergic reaction which can rarely occur after vaccination. There is limited data suggesting that the majority of the patients with immediate and potentially allergic reactions after the first dose of coronavirus disease 2019 (COVID-19) can receive the second dose.\u00a0A 39-year-old woman was admitted to our department\u00a0after presenting\u00a0anaphylactic reaction following the first dose of mRNA COVID-19 vaccine (BNT162b2).\u00a0A few days later, she contacted our department and was admitted for an allergy work-up on mRNA COVID-19 vaccine and its compound polyethylene glycol (PEG). Thereafter, she completed the vaccination procedure having received pretreatment under our guidance. Confirmed allergic reactions to vaccines are customarily attributed\u00a0to the inactive ingredients, or excipients like PEG and polysorbate. The latest are used to improve water-solubility in\u00a0vaccines. PEG itself has not been previously used in a vaccine but polysorbate has been identified as a rare cause of allergic reactions to vaccines.\u00a0It has been reported that the interaction of the immune system with lipidic nanoparticle therapeutics could result in hypersensitivity reactions (HSRs), referred to as complement activation related pseudoallergy (CARPA), which is classified as non-IgE-mediated pseudoallergy caused by the activation of the complement system.", "lang": "en", "keywords": "", "favicon": "https://assets.cureus.com/packs/media/images/favicon-6b3259c58f4356da2cc885357cfda20b.png", "canonical": "https://www.cureus.com/articles/114605-administration-of-the-second-dose-of-mrna-covid-19-vaccine-to-a-woman-with-immediate-reaction-to-the-first-dose", "encoding": "utf-8"}, "image": null, "domain": "www.cureus.com", "title": "Administration of the Second Dose of mRNA COVID-19 Vaccine to a Woman With Immediate Reaction to the First Dose", "cleaned_text": "On May 25, 2018, the GDPR (General Data Protection Regulation) went into effect and changed how organizations deal with personal data of customers located in the EU. Though GDPR was built to protect Europeans, it will affect organizations around the world doing business in the EU. Because of this we are asking our users located in the EU to opt in to the data we collect in order to bring a better web experience. Opt-In", "opengraph": {"title": "Administration of the Second Dose of mRNA COVID-19 Vaccine to a Woman With Immediate Reaction to the First Dose", "type": "article", "image": "https://public.cureus.com/fallback/new_default_article_image_2.png", "description": "Vaccines constitute the most effective\u00a0public health intervention as they\u00a0prevent the spread of infectious diseases and reduce disease severity and mortality. Allergic reactions can occur during vaccination. Systemic anaphylaxis is a severe, life-threatening allergic reaction which can rarely occur after vaccination. There is limited data suggesting that the majority of the patients with immediate and potentially allergic reactions after the first dose of coronavirus disease 2019 (COVID-19) can receive the second dose.\u00a0A 39-year-old woman was admitted to our department\u00a0after presenting\u00a0anaphylactic reaction following the first dose of mRNA COVID-19 vaccine (BNT162b2).\u00a0A few days later, she contacted our department and was admitted for an allergy work-up on mRNA COVID-19 vaccine and its compound polyethylene glycol (PEG). Thereafter, she completed the vaccination procedure having received pretreatment under our guidance. Confirmed allergic reactions to vaccines are customarily attributed\u00a0to the inactive ingredients, or excipients like PEG and polysorbate. The latest are used to improve water-solubility in\u00a0vaccines. PEG itself has not been previously used in a vaccine but polysorbate has been identified as a rare cause of allergic reactions to vaccines.\u00a0It has been reported that the interaction of the immune system with lipidic nanoparticle therapeutics could result in hypersensitivity reactions (HSRs), referred to as complement activation related pseudoallergy (CARPA), which is classified as non-IgE-mediated pseudoallergy caused by the activation of the complement system."}, "tags": [], "tweets": [], "movies": [], "links": ["/users/gdpr_opt_in"], "authors": ["Anastasia Papadopoulou", "Evangelia Kompoti", "Konstantina Dimitriou", "Evaggelia Apostolidou", "Nikolaos Mikos"], "publish_date": null}